Study | No of subjects | Epworth Sleepiness Score | AHI | Placebo | Outcome | Comments |
---|---|---|---|---|---|---|
AHI, apnoea/hypopnoea index; BP, blood pressure; CPAP, continuous positive airway pressure; RDI, respiratory disturbance index; RCT, randomised controlled trial. | ||||||
Faccenda17 | 68 | Mean 15 | Mean 35 | Placebo tablet | 1.5 mm Hg diastolic BP fall with CPAP | Subgroup analysis showed greatest BP fall in those with most severe disease (RDI >20) |
Dimsdale20 | 39 | Not documented | Mean RDI 48.1 | Sham CPAP | About 5 mm Hg mean nocturnal BP fall | One week treatment; fall in daytime BP in placebo group at 1 week |
Barbe18 | 55 | Mean 7 | Mean 56 | Sham CPAP | No change in BP | Patients with no hypersomnolence compared with other RCTs |
Pepperell1 | 95 | Mean 16 | Mean 4% >dip rate 37 | Sham CPAP | Mean BP fall 3.3 mm Hg | Subgroup analysis showed greatest BP fall in those on antihypertensives |
Monasterio22 | 125 | Mean 12.6 | Mean 20 | Conservative treatment | No change in BP at 3 and 6 months | No BP effect in patients with mild disease |
Becker19 | 32 | Mean 14 | Mean 64 | Partially therapeutic sham CPAP | Mean BP fall 9.9 mm Hg | 9 weeks of treatment, more severe disease, two-thirds on antihypertensives |